Hypobarotherapy and cardiovascular risk factor correction in women in early postmenopause

Abstract

Aim. To assess the role of hypobarotherapy in the correction of cardiovascular disease (CVD) risk factors (RF) among women in early postmenopause. Material and methods. The hypobaric hypoxia adaptation method (Ural-1 barochamber, 22 daily three-hour sessions; simulated altitude 3500 m, or 460 mm Hg) was used for the metabolic syndrome treatment in 56 women (mean age 53,6±3,1 years) in early postmenopause. Results. The treatment-induced decrease reached 53,5% for modified menopausal index; 6,1% for body mass; 13,4% and 7,3% for systolic and diastolic blood pressure; 19,5% for cholesterol; 21,3% for glucose; and 20,2% for insulin. Systolic and diastolic left ventricular function parameters also improved. Conclusion. Hypobarotherapy was an effective method for the CVD RF correction among women in early postmenopause.

Keywords

• postmenopause
• metabolic syndrome
• hypobarotherapy